Revolution Medicines Inc.
Organization details
- Legal name
- Revolution Medicines Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Redwood City
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RVMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001628171
- EIN
- 47-2029180
- Wikidata ID
- Q107518109
Board of directors
- Since 2023
-
Barbara Weber · DirectorSince 2023
-
Elizabeth M. Anderson · DirectorSince 2023
-
Eric Thomas Schmidt · DirectorSince 2023
-
Flavia Borellini · DirectorSince 2023
-
Frank Clyburn · DirectorSince 2024
-
Lorence H. Kim · DirectorSince 2023
-
Mark A. Goldsmith · Director · See RemarksSince 2023
-
Sandra Horning · DirectorSince 2023
-
Sushil Patel · DirectorSince 2023
-
Thilo Schroeder · DirectorSince 2023
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.1%
-
98.0%
Board connections
9 of this board's directors also sit on 14 other boards. 14 are in the same sector.
-
Cencora Inc. Same sectorvia Frank Clyburn and Lorence H. Kim
-
Parabilis Medicines Inc. Same sectorvia Alexis Borisy and Barbara Weber
-
Tango Therapeutics Inc. Same sectorvia Alexis Borisy and Barbara Weber
-
BioMarin Pharmaceutical Inc. Same sectorvia Elizabeth M. Anderson
-
Gilead Sciences Inc. Same sectorvia Sandra Horning
-
Insmed Incorporated Same sectorvia Elizabeth M. Anderson
-
Kailera Therapeutics Inc. Same sectorvia Frank Clyburn
-
Moderna Inc. Same sectorvia Sandra Horning
-
OPKO Health Inc. Same sectorvia Alexis Borisy
-
Olema Pharmaceuticals Inc. Same sectorvia Sandra Horning
-
Pliant Therapeutics Inc. Same sectorvia Flavia Borellini
-
Relay Therapeutics Inc. Same sectorvia Alexis Borisy
-
Relmada Therapeutics Inc. Same sectorvia Eric Thomas Schmidt
-
Replimune Group Inc. Same sectorvia Sushil Patel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $151,762,848
- 157 sales by 12 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 26, 2026 | Mancini Anthony Officer (See Remarks) | Option exercise | +2,310 | $33.62 | $77,662 |
| Oct 26, 2026 | Mancini Anthony Officer (See Remarks) | Open-market sale | −2,310 | $186.99 | $431,947 |
| Sep 29, 2026 | Alan B. Sandler Officer (Chief Development Officer) | Option exercise | +6,000 | $58.84 | $353,040 |
| Sep 29, 2026 | Alan B. Sandler Officer (Chief Development Officer) | Open-market sale | −2,200 | $200.82 | $441,801 |
| Sep 29, 2026 | Alan B. Sandler Officer (Chief Development Officer) | Open-market sale | −1,609 | $201.72 | $324,574 |
| Sep 29, 2026 | Alan B. Sandler Officer (Chief Development Officer) | Open-market sale | −1,000 | $202.81 | $202,813 |
| Sep 29, 2026 | Alan B. Sandler Officer (Chief Development Officer) | Open-market sale | −1,199 | $203.91 | $244,485 |
| Sep 29, 2026 | Alan B. Sandler Officer (Chief Development Officer) | Open-market sale | −301 | $204.72 | $61,621 |
| Sep 25, 2026 | Cislini Jeff Officer (SVP & General Counsel) | Open-market sale | −765 | $207.32 | $158,600 |
| Sep 25, 2026 | Mancini Anthony Officer (See Remarks) | Option exercise | +3,121 | $33.62 | $104,928 |
| Sep 25, 2026 | Mancini Anthony Officer (See Remarks) | Open-market sale | −3,121 | $200.54 | $625,885 |
| Sep 24, 2026 | Mancini Anthony Officer (See Remarks) | Open-market sale | −587 | $200.00 | $117,400 |
| Sep 22, 2026 | Elizabeth M. Anderson Director | Option exercise | +5,070 | $1.12 | $5,678 |
| Sep 22, 2026 | Elizabeth M. Anderson Director | Open-market sale | −910 | $191.85 | $174,584 |
| Sep 22, 2026 | Elizabeth M. Anderson Director | Open-market sale | −4,985 | $192.54 | $959,812 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Revolution Medicines Inc.
How many directors are on Revolution Medicines Inc.'s board?
Revolution Medicines Inc.'s board has 11 directors: Alexis Borisy, Barbara Weber, Elizabeth M. Anderson, Eric Thomas Schmidt, Flavia Borellini, Frank Clyburn, Lorence H. Kim, Mark A. Goldsmith, Sandra Horning, Sushil Patel and 1 other.
Are Revolution Medicines Inc. insiders buying or selling shares?
Over the last 12 months, Revolution Medicines Inc. insiders made no open-market purchases and sold $151.8 million of shares in 157 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="revolution-medicines-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.